Epomediol ameliorates pruritus in patients with intrahepatic cholestasis of pregnancy
Manuel C. González +8 more
openalex +2 more sources
BL‐Predictor has emerged as a new tool for delabeling penicillin allergy. External validation has shown a specificity of 93% for detecting low‐risk patients. This score could potentially reduce diagnostic costs and the negative consequences associated with incorrect antibiotic allergy labels.
Marina Labella +14 more
wiley +1 more source
Therapeutic Effectiveness of Narrowband-Ultraviolet B Phototherapy in Uremic Pruritus Patients with Chronic Kidney Disease Undergoing Hemodialysis - A Prospective Study. [PDF]
Senguttuvan K +2 more
europepmc +1 more source
Temporal and external validation of the multidimensional scale—uremic pruritus in dialysis patients (
Sirinda Jamjanya +10 more
openalex +1 more source
Improvement in Irretractable Pruritus With Intrahepatic Portosystemic Shunt Embolization: From MAID to a New Lease on Life. [PDF]
Bagha A +4 more
europepmc +1 more source
Integrated Clinical Trial and Molecular Profiling Reveals Immune Drivers of Chronic Hand Eczema
This study performed an unbiased molecular profiling of CHE patients across diverse etiologies to identify shared pathogenic drivers and evaluate the impact of IL‐4Rα blockade via dupilumab over 16 weeks. CHE shows a mixed immune signature involving type 1, 2, and 3 pathways with features of atopic dermatitis and psoriasis.
Perrine Gery +25 more
wiley +1 more source
Impact of Mycosis Fungoides/Sézary Syndrome on Patients' and Cohabitants' Quality of Life-A Cross-Sectional Study. [PDF]
Łyko M, Jankowska-Konsur A.
europepmc +1 more source
Pregabalin as a Potential Adjunct in the Management of Pruritus in Prurigo Nodularis: A Case Report [PDF]
Yoshihito Mima +2 more
openalex +1 more source
Dupilumab‐Associated Palmar Erythema Successfully Treated With Fluconazole
Australasian Journal of Dermatology, EarlyView.
Katina J. Selvaraj, Geoffrey Lee
wiley +1 more source
This study evaluated safety and tolerability of birch pollen SCIT during dose escalation with a new One‐Strength regimen (3 injections, Strength B) compared to the Standard regimen (7 injections, Strengths A and B) in patients aged 5–65 years. Safety and tolerability were comparable between the two regimens in adults, adolescents, and adolescents, as ...
Marek Jutel +5 more
wiley +1 more source

